目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T7395 | PPAR | ||
Lanifibranor (IVA337) 是泛过氧化物酶体增殖物激活受体 (PPAR) 激动剂,对人类PPARα,PPARσ和PPARγ的EC50值分别为 1.5, 0.87 和 0.21 μM。 | |||
T19211 | Others | ||
BM152054 是一种有效的 PPARγ配体,可以通过加强胰岛素作用来诱导外周组织对葡萄糖的利用。 | |||
T15581 | PPAR | ||
Inolitazone (RS5444) 是一种高亲和力PPARγ激动剂。在体外,Inotazone 显示生长抑制的IC50约为0.8 nM。 | |||
T26986 | PPAR | ||
Cevoglitazar (LBM-642) 是一种 PPARɑ 激动剂和 PPARγ激动剂。Cevoglitazar 能有效减少肥胖小鼠和猴的食物摄入量和体重。 | |||
T15440 | PPAR | ||
GSK376501A 是一种具有选择性和有效性的的过氧化物酶体增殖物激活受体 γ (PPARγ) 调节剂,可用于研究 2 型糖尿病。 | |||
T19710 | Apoptosis p38 MAPK PPAR | ||
Ciglitazone (ADD 3878) 是一种强效和选择性的PPARγ激动剂(EC50:3μM)和口服降糖药。Ciglitazone 抑制th17细胞的增殖和分化,降低胰岛素水平、血管内皮生长因子的产生和血压,诱导胃癌细胞的细胞周期停止。Ciglitazone 能诱导负鼠肾上皮细胞的凋亡,激活p38 MAPK 和凋亡诱导因子(AIF)的核转位。 Ciglitazone 在肥胖症和高血糖症的动物模型中表现出降血糖活性。 | |||
T21764 | PPAR | ||
MCC-555 (Isaglitazone) 是一种 PPARα 和 PPARγ 激动剂,具有抗高血糖作用。 | |||
T24827 | PPAR | ||
SR 16832 是一种化学合成中的砌块 | |||
T3917 | PPAR | ||
Protopanaxatriol (20(R)-APPT) 是天然的人参皂苷的糖苷配基,包括 Re,Rf,Rg1,Rg2 和 Rh。 | |||
T28501 | PPAR | ||
Ragaglitazar(NNC-61-0029) 是一种有效的 PPARα和 PPARγ双重激动剂,在动物模型中显示出有效的降脂和胰岛素增敏作用。Ragaglitazar 可用于研究 2 型糖尿病。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-02575 | PPAR gamma/PPARG Protein, Human, Recombinant (His & GST) | Human | Baculovirus Insect Cells | ||
Peroxisome proliferator-activated receptor gamma (PPARG), a nuclear hormone receptor, plays a critical role in the lipid and glucose homeostasis, adipocyte differentiation, as well as intracellular insulin-signaling events. The peroxisome proliferator-activated receptor gamma (PPARgamma) regulates osteoblast and osteoclast differentiation, and is the molecular target of thiazolidinediones (TZDs), insulin sensitizers that enhance glucose utilization and adipocyte differentiation. Peroxisome proliferator-activated receptor gamma (PPARG) is a transcription factor involved in atherosclerosis and related diseases. Peroxisome proliferator-activated receptor gamma (PPARG) plays an important role in the pathogenesis and maintenance of essential hypertension (EH).The functional single nucleotide polymorphisms in peroxisome proliferator-activated receptor gamma (PPARG) gene were predicted to be correlated with the susceptibility of colorectal cancer (CRC).
|
|||||
TMPH-02827 | PPAR gamma Protein, Mouse, Recombinant (His) | Mouse | E. coli | ||
PPAR gamma Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 63.3 kDa and the accession number is P37238.
|
|||||
TMPY-06830 | PPAR alpha/PPARA Protein, Human, Recombinant (His) | Human | E. coli | ||
PPAR alpha/PPARA Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 31.36 kDa and the accession number is Q07869.
|
|||||
TMPH-03711 | PPAR gamma Protein, Xenopus laevis, Recombinant (His) | Xenopus laevis | E. coli | ||
Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the receptor binds to a promoter element in the gene for acyl-CoA oxidase and activates its transcription. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. May play a role in the regulation of circadian rhythm.
|
|||||
TMPY-06837 | PPAR alpha/PPARA Protein, Mouse, Recombinant (His) | Mouse | E. coli | ||
PPAR alpha/PPARA Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 31.49 kDa and the accession number is P23204.
|